Arovella Therapeutics (ASX:ALA) partners with Imugene (ASX:IMU)
29 Sep 2022 - Arovella Therapeutics Limited (ASX:ALA) Managing Director and CEO Michael Baker discusses the company's collaboration with Imugene to combine therapies.